Advanced search
Start date
Betweenand

Role of methotrexate and pro-resolving mediators in rheumatoid arthritis and in inflammatory response resolution process

Grant number: 17/06007-8
Support type:Scholarships in Brazil - Post-Doctorate
Effective date (Start): June 01, 2017
Effective date (End): March 31, 2019
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Principal researcher:Paulo Louzada Junior
Grantee:Livia Correa Barroso
Home Institution: Faculdade de Medicina de Ribeirão Preto (FMRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
Associated research grant:13/08216-2 - CRID - Center for Research in Inflammatory Diseases, AP.CEPID

Abstract

The Center for Research in Inflammatory Diseases (CRID-CEPID) investigate the mechanisms and molecules involved in inflammation. In recent years has increased the number of studies involving the concept of resolution in inflammatory response. For a long time believed resolution was a passive process, but today is know that a complex and actively controlled process involving endogenous cells and mediators prevent uncontrolled inflammation, removing neutrophils in apoptosis, and returning the organism to homeostasis. Therefore, understand the mechanisms of resolution and new pro-resolving mediators are very important. In this sense, this work has as main objectives: study the role of methotrexate treatment in the course of inflammatory resolution and investigate the role of pro-resolving mediators in the resolution of the inflammatory response and in the course of the rheumatoid arthritis.

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Please report errors in scientific publications list by writing to: cdi@fapesp.br.